Premium
Ocular complications after intracarotid BCNU for intracranial tumors
Author(s) -
Elsås Tor,
Watne Kjell,
Fostad Kristen,
Hager Bjarne
Publication year - 1989
Publication title -
acta ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/j.1755-3768.1989.tb00728.x
Subject(s) - medicine , oculomotor nerve palsy , paresis , palsy , amaurosis , surgery , oculomotor nerve , occlusion , ophthalmology , alternative medicine , pathology
112 patients with intracranial tumors treated with intracarotid BCNU to a cumulative dose of 370 mg/m 2 body surface have been examined retrospectively for ocular complications. Average follow‐up was 494 days (range 5 months‐5 years). The rate of ocular complications was 2.7%. There was 1 case of hemorrhagic glaucoma with amaurosis and an accompanying oculomotor palsy, 1 case of retinal branch artery occlusion combined with third nerve paresis and 1 case of oculomotor palsy.